Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A

Author(s):  Blankenship Cynthia E

Issue:  Sep/Oct 2014 - Volume 18, Number 5
View All Articles in Issue

Page(s):  379-380

Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Page 1
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Page 2

Download in electronic PDF format for $65

Abstract:  

Related Keywords: Cynthia E. Blankenship, Esq., US Food and Drug Administration, FDA, Section 503A of the Food, Drug, and Cosmetic Act, International Academy of Compounding Pharmacists, IACP, drug safety, do not compound list, bulk drug substances list, office use, repackaging, Partnership for Personalized Prescriptions

Related Categories: LEGAL, PACKAGING

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Blankenship Cynthia E
Sep/Oct 2014
Pg. 379-380

Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
Sep/Oct 2021
Pg. 358-362

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)
Nov/Dec 2016
Pg. 457-458

U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Miller David G
May/Jun 2014
Pg. 208

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

The "Lists": What Do They Mean?
Voliva John
Nov/Dec 2016
Pg. 477-479

U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488

Standing Together Fixing the Drug Quality and Security Act
Miller David G
Mar/Apr 2015
Pg. 104-106

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions